Applied Therapeutics
We have no price for Applied Therapeutics since 4 February 2026. It may have been taken over, merged or renamed, so the figures below are from then.
Trading close to its lowest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here.
Applied Therapeutics vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Applied Therapeutics | No profit yet | ||
 Vertex Pharmaceuticals | 35.3× · Expensive | ||
 Moderna | No profit yet | ||
 Regeneron Pharmaceuticals | 21.1× · Fair price | ||
 CSL | 22.2× · Fair price |
AI analysis
An AI analyst reads Applied Therapeutics's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Profitability
- –
- –
- –
- –
- –
- –
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- –
Financial health
- –
- –
- –
- –
- –
- –
- –
What analysts expect
- Average price target
- $0.25
- Range
- $0.25 – $0.25
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Nov 13, 2025 | -0.13 | -0.14 | +7.5% |
| Aug 13, 2025 | -0.15 | -0.17 | +10.9% |
| May 13, 2025 | -0.15 | -0.18 | +17.4% |
| Apr 14, 2025 | 0.32 | -0.18 | +272.4% |
| Nov 7, 2024 | -0.48 | -0.16 | −200.8% |
| Aug 7, 2024 | 0.02 | -0.16 | +112.2% |
| May 9, 2024 | -0.67 | -0.16 | −320.2% |
| Mar 6, 2024 | -0.45 | -0.19 | −139.5% |
News
IREN Falls 5% After Friday’s 20% Surge as AI Lending Worries Mount; TeraWulf and Applied Digital Rise 2%Yahoo Finance · Nov 9, 2026Applied Materials, Cisco, Berkshire Hathaway, Nvidia, Micron and Alphabet are part of Zacks Earnings PreviewYahoo Finance · Nov 9, 2026Coherent, Applied Optoelectronics upgraded by Northland on Marvell deal for LumentumSeeking Alpha · Nov 2, 2026Applied Materials (AMAT) Slides Despite EPS Surge and Higher Analyst EstimatesYahoo Finance · Nov 2, 2026What Changed For Applied Digital Stock, And What Did Not?Yahoo Finance · Oct 22, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/3Passes 0 of 3. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Questions about Applied Therapeutics
Is Applied Therapeutics a good stock to buy?
We do not have this company's yearly figures yet, so its profit, growth, price and debt cannot be judged here. 0 of the 3 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Applied Therapeutics AI analysis
What does Applied Therapeutics do?
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for cardiovascular conditions, galactosemia, and various diabetes-related complications. It is in Biotechnology.
Who are Applied Therapeutics's competitors?
The largest listed companies in the same industry are Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals and CSL. The peers table on this page compares their profit, growth and price with Applied Therapeutics's.
Prices: daily closes to Feb 4, 2026. Fundamentals: company reports via invest-like data.